Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity


Autoria(s): Higuchi, Célio Takashi; Sannomiya, M.; Pavan, Fernando Rogério; Leite, S. R. A.; Sato, D. N.; Franzblau, S. G.; Sacramento, Luis Vitor Silva do; Vilegas, Wagner; Leite, Clarice Queico Fujimura
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/01/2011

Resumo

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Processo FAPESP: 02/05503-6

Bioassay-guided fractionation of the chloroform extract of Byrsonima fagifolia leaves led to the isolation of active antitubercular compounds alkane dotriacontane (Minimal Inhibitory Concentration-MIC, 62.5 mu g mL(-1)), triterpenoids as bassic acid (MIC = 2.5 mu g mL(-1)), alpha-amyrin acetate (MIC = 62.5 mu g mL(-1)), a mixture of lupeol, alpha- and beta-amyrin (MIC = 31.5 mu g mL(-1)) and a mixture of lupeol, and acetates of alpha- and beta-amyrin (MIC = 31.5 mu g mL(-1)). The antimycobacterial activity was determined by the Microplate Alamar Blue Assay (MABA) and the structures of promising compounds were determined by spectroscopic analysis. This investigation constitutes the first report of a chemical and antitubercular study of apolar compounds from B. fagifolia Niedenzu (IK).

Formato

5

Identificador

http://dx.doi.org/10.1093/ecam/nen077

Evidence-based Complementary and Alternative Medicine. New York: Hindawi Publishing Corporation, p. 5, 2011.

1741-427X

http://hdl.handle.net/11449/7499

10.1093/ecam/nen077

WOS:000293355700001

WOS000293355700001.pdf

Idioma(s)

eng

Publicador

Hindawi Publishing Corporation

Relação

Evidence-based Complementary and Alternative Medicine

Direitos

openAccess

Tipo

info:eu-repo/semantics/article